Skip to content

Clinical trials

Phase 2 Opioid-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 2 Clear all

213 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20025
20031
20047
20058
20065
20075
20086
20091
20104
20128
20137
20141
20155
20161
20172
20185
20196
20207
202113
202211
20237
202411
202511
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Recruiting25
Withdrawn22
Terminated16
Unknown status7
Not yet recruiting5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)35
Yale University22
New York State Psychiatric Institute15
Johns Hopkins University14
University of Vermont8
Indivior Inc.7
University of Chicago7
University of Colorado, Denver7
Brigham and Women's Hospital6
University of Maryland, Baltimore5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders213
Substance-Related Disorders36
Heroin Dependence15
Cocaine-Related Disorders12
Chronic Pain11
Pain7
Agnosia5
HIV Infections4
Narcotic-Related Disorders4
Acquired Immunodeficiency Syndrome3

Trials

Showing 51 to 75 of 213. Each trial links to its page on Pharma Observatory.

113 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.